Pharmesis International Ltd. (SGX:BFK)

Pharmesis International Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.35	4.31	4.6	9.48	19.72	13.98
Cash & Short-Term Investments	5.35	4.31	4.6	9.48	19.72	13.98
Cash Growth	64.03%	-6.34%	-51.42%	-51.94%	41.09%	-7.97%
Accounts Receivable	7.65	16.1	36.01	6.76	11.64	12.8
Other Receivables	1.09	1.51	1.69	1.55	1.29	1.4
Receivables	8.74	17.61	37.7	8.31	12.93	14.2
Inventory	14.2	16.3	14.15	15.37	11.09	8.81
Prepaid Expenses	0.1	0.03	0.06	0.13	0.42	0.16
Total Current Assets	28.39	38.25	56.52	33.28	44.15	37.14
Property, Plant & Equipment	15.31	16.16	56.59	50.2	51.33	53.12
Goodwill	1.32	1.32	1.32	1.32	1.32	1.32
Long-Term Deferred Tax Assets	0.06	0.06	0.32	-	-	-
Other Long-Term Assets	39.35	39.94	1.1	1.1	1.1	1.1
Total Assets	84.43	95.73	115.85	85.9	97.9	92.68

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.16	11.48	25.06	5.98	5.17	4.43
Accrued Expenses	10.64	2.08	1.93	2.38	3.87	2.66
Short-Term Debt	15	15	15	15	15	15
Current Portion of Leases	0.22	0.4	0.57	0.45	0.2	0.39
Current Income Taxes Payable	0.02	0.14	0.14	0.14	0.18	0.22
Other Current Liabilities	-	10.8	10.89	6.68	15.18	8.09
Total Current Liabilities	33.05	39.89	53.58	30.63	39.6	30.79
Long-Term Leases	0.2	0.3	0.69	1.08	1.34	1.75
Total Liabilities	33.25	40.19	54.27	31.71	40.93	32.54

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	54.84	54.84	88.45	85.84	83.71	83.71
Retained Earnings	7.2	11.56	-16.02	-24.3	-19.34	-15.78
Comprehensive Income & Other	-10.85	-10.85	-10.85	-10.47	-10.47	-10.47
Total Common Equity	51.19	55.55	61.57	51.07	53.9	57.46
Minority Interest	-	-	-	3.12	3.06	2.68
Shareholders' Equity	51.19	55.55	61.57	54.19	56.97	60.14
Total Liabilities & Equity	84.43	95.73	115.85	85.9	97.9	92.68

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	15.42	15.7	16.26	16.52	16.53	17.14
Net Cash (Debt)	-10.07	-11.38	-11.66	-7.05	3.19	-3.16
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.32	-0.36	-0.39	-0.27	0.14	-0.14
Filing Date Shares Outstanding	31.7	31.7	31.7	27.6	23	23
Total Common Shares Outstanding	31.7	31.7	31.7	27.6	23	23
Working Capital	-4.66	-1.64	2.94	2.65	4.56	6.35
Book Value Per Share	1.61	1.75	1.94	1.85	2.34	2.50
Tangible Book Value	49.86	54.22	60.25	49.75	52.58	56.14
Tangible Book Value Per Share	1.57	1.71	1.90	1.80	2.29	2.44
Buildings	-	34.03	66.45	33.83	35.22	35.22
Machinery	-	28.52	30.73	27.55	27.25	27.08
Construction In Progress	-	-	-	35.43	35.4	35.4
Leasehold Improvements	-	2.97	2.97	2.97	2.97	2.97

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error